版本:
中国

BRIEF-Abivax initiates clinical trial (ABX464-005) to evaluate effect of ABX464 on HIV-reservoirs in HIV patients

April 4 Abivax SA:

* Initiates clinical trial (ABX464-005) to evaluate the effect of ABX464 on HIV-reservoirs in HIV patients

* Initial results are expected in Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐